Aker BioMarine AS reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 61.97 million compared to USD 70.18 million a year ago. Net income was USD 13.5 million compared to USD 2.38 million a year ago. Basic earnings per share from continuing operations was USD 0.15 compared to USD 0.03 a year ago. Diluted earnings per share from continuing operations was USD 0.15 compared to USD 0.03 a year ago. For the nine months, sales was USD 186.34 million compared to USD 213.09 million a year ago. Net income was USD 0.442 million compared to net loss of USD 8.4 million a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to basic loss per share from continuing operations of USD 0.13 a year ago. Diluted earnings per share from continuing operations was USD 0.01 compared to diluted loss per share from continuing operations of USD 0.13 a year ago.